Tilray Inc (NASDAQ:TLRY – Get Free Report) dropped 2.4% during mid-day trading on Friday . The stock traded as low as $1.80 and last traded at $1.81. Approximately 5,390,867 shares changed hands during trading, a decline of 79% from the average daily volume of 25,920,676 shares. The stock had previously closed at $1.85.
Tilray Stock Performance
The firm’s fifty day simple moving average is $1.79 and its 200 day simple moving average is $1.89. The company has a market capitalization of $1.40 billion, a price-to-earnings ratio of -4.10 and a beta of 2.19. The company has a debt-to-equity ratio of 0.10, a current ratio of 2.27 and a quick ratio of 1.42.
Tilray (NASDAQ:TLRY – Get Free Report) last issued its quarterly earnings results on Monday, July 29th. The company reported ($0.04) EPS for the quarter, missing the consensus estimate of ($0.02) by ($0.02). Tilray had a negative net margin of 30.26% and a negative return on equity of 2.63%. The firm had revenue of $229.90 million during the quarter, compared to analysts’ expectations of $226.20 million. During the same quarter last year, the company posted ($0.15) EPS. The firm’s revenue was up 24.8% compared to the same quarter last year. On average, sell-side analysts forecast that Tilray Inc will post -0.12 EPS for the current year.
Institutional Trading of Tilray
Tilray Company Profile
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
See Also
- Five stocks we like better than Tilray
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- The Cannabis Sector: Profitability Takes Center Stage
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Amazon’s Stock Plunge: Is a Prime Buying Opportunity Knocking?
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Buy the Dip in e.l.f. Beauty: Analysts Point to a New High
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.